{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:12:49Z","timestamp":1793124769541,"version":"4.5.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,16]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Hemorrhagic fever with renal syndrome (HFRS) is a kind of natural epidemic diseases with rodents as the main source of infection. The main clinical manifestations of HFRS are fever, hemorrhage, congestion, hypotensive shock and kidney damage. Some studies showed that vaccination populations in infected areas with inactivated vaccines can reduce the incidence of the disease, but there are variations in protection rates among these studies. The aim of this study is to systematically evaluate the protective effect of inactivated vaccines against HFRS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Web of Science, PubMed, SinoMed, Proquest, China National Knowledge Infrastructure Database, Wanfang Database, VIP Database were searched from their inception to December 2024. Newcastle-Ottawa Scale (NOS) was used to assess the quality of evidence, and a random-effects meta-analysis was done to calculate pooled risk ratios for vaccination uptake. All the relevant data were analyzed by using STATA 15.0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 15 articles were included, all of which explicitly reported the total number of vaccinated and unvaccinated people in the vaccination group, and the number of cases that developed during the observation period. Six of these articles reported positive antibody transfer rates. The protection rate of the inactivated HFRS vaccine reached 86%, and a subgroup analysis showed that there was a significant difference in the protection rate of the inactivated vaccine between Korea and China. The positive IgG antibody transfer rate was 97%, and neutralizing antibody transfer rate was 37%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The results indicated that inactivated vaccine has a good protective effect against HFRS and should be universally administered to populations in high prevalence areas to control the harm caused by HFRS epidemics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000042463","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T14:00:45Z","timestamp":1747836045000},"page":"e42463","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["The protective efficacy of inactivated vaccine against hemorrhagic fever with renal syndrome: A meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Weiting","family":"Wu","sequence":"first","affiliation":[{"name":"Youth Research and Innovation Team of Jiangxi Provincial Center for Disease Control and Prevention, Nanchang, Jiangxi, China"},{"name":"School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"},{"name":"Jiangxi Provincial Key Laboratory of Disease Prevention and Public Health, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1856-8564","authenticated-orcid":false,"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Youth Research and Innovation Team of Jiangxi Provincial Center for Disease Control and Prevention, Nanchang, Jiangxi, China"},{"name":"Institute of Immunization Program, Jiangxi Provincial Center for Disease Control and Prevention, Nanchang, Jiangxi, China"},{"name":"Provincial Key Laboratory of Major Epidemic Prevention and Control, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicheng","family":"Guo","sequence":"additional","affiliation":[{"name":"Institute of Immunization Program, Jiangxi Provincial Center for Disease Control and Prevention, Nanchang, Jiangxi, China"},{"name":"Provincial Key Laboratory of Major Epidemic Prevention and Control, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhao","sequence":"additional","affiliation":[{"name":"Youth Research and Innovation Team of Jiangxi Provincial Center for Disease Control and Prevention, Nanchang, Jiangxi, China"},{"name":"School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"},{"name":"Jiangxi Provincial Key Laboratory of Disease Prevention and Public Health, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuli","family":"Yang","sequence":"additional","affiliation":[{"name":"Medical Service Department, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260811","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12879-020-4775-8","article-title":"Peritonitis secondary to hemorrhagic fever with renal syndrome: a case report in GuangZhou China.","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R2-20260811","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.3389\/fmicb.2019.02989","article-title":"Vaccines and therapeutics against hantaviruses.","volume":"10","author":"Liu","year":"2019","journal-title":"Front Microbiol"},{"key":"R3-20260811","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1586\/14787210.2015.1047825","article-title":"Diagnosis of hantavirus infection in humans.","volume":"13","author":"Matter","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R4-20260811","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s40506-020-00236-3","article-title":"Hantavirus infections-treatment and prevention.","volume":"12","author":"Dheerasekare","year":"2020","journal-title":"Curr Treat Options Infect Dis"},{"key":"R5-20260811","doi-asserted-by":"crossref","first-page":"366","DOI":"10.23876\/j.krcp.18.0044","article-title":"Effectiveness of inactivated hantavirus vaccine on the disease severity of hemorrhagic fever with renal syndrome.","volume":"37","author":"Yi","year":"2018","journal-title":"Kidney Res Clin Pract"},{"key":"R6-20260811","first-page":"471","article-title":"Research progress of therapeutic strategy against hemorrhagic fever with renal syndrome.","volume":"27","author":"Xiu-Yun","year":"2021","journal-title":"Chin J Hyg Insectic Equip"},{"key":"R7-20260811","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/bs.aivir.2019.07.002","article-title":"Hantavirus entry: perspectives and recent advances.","volume":"104","author":"Mittler","year":"2019","journal-title":"Adv Virus Res"},{"key":"R8-20260811","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3390\/v15020561","article-title":"Hemorrhagic fever with renal syndrome in asia: history, pathogenesis, diagnosis, treatment, and prevention.","volume":"15","author":"Sehgal","year":"2023","journal-title":"Viruses"},{"key":"R9-20260811","doi-asserted-by":"crossref","first-page":"545371","DOI":"10.3389\/fcimb.2020.545371","article-title":"Various adjuvants effect on immunogenicity of Puumala virus vaccine.","volume":"10","author":"Kurashova","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"R10-20260811","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3349\/ymj.2001.42.3.278","article-title":"Primary humoral immune responses to formalin inactivated hemorrhagic fever with renal syndrome vaccine (Hantavax): consideration of active immunization in South Korea.","volume":"42","author":"Sohn","year":"2001","journal-title":"Yonsei Med J"},{"key":"R11-20260811","first-page":"90","article-title":"Research progress of hantavirus vaccine.","volume":"28","author":"You","year":"2022","journal-title":"Chin J Hyg Insectic Equip"},{"key":"R12-20260811","first-page":"270","article-title":"Vaccine effectiveness and immunogenicity of hemorrhagic fever with renal syndrome vaccine among 60-70-year-olds in Huyi district of Shaanxi province.","volume":"27","author":"Qing","year":"2021","journal-title":"Chin J Vaccines Immunization"},{"key":"R13-20260811","first-page":"14","article-title":"An observation of the immune effects of inactivated vaccine for hemorrhagic fever with renal syndrome.","volume":"14","author":"Hongjie","year":"2002","journal-title":"J Prev Med"},{"key":"R14-20260811","first-page":"104","article-title":"Literature analysis of the research status and effect on hantavirus vaccine.","volume":"28","author":"Qiu-Wei","year":"2021","journal-title":"Acta Parasit Med Entomol Sinica"},{"key":"R15-20260811","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1016\/S0264-410X(02)00317-1","article-title":"Sample size determination for phase II studies of new vaccines.","volume":"20","author":"Rao","year":"2002","journal-title":"Vaccine"},{"key":"R16-20260811","doi-asserted-by":"crossref","first-page":"e40315","DOI":"10.1097\/MD.0000000000040315","article-title":"Migraine and the correlation between stroke: a systematic review and meta-analysis.","volume":"103","author":"Zhao","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"R17-20260811","first-page":"36","article-title":"Evaluation on the efficacy of immunization and epidemiology of type I inactivated vaccines against HFRS in an Anhui province.","volume":"15","author":"Yiyin","year":"1999","journal-title":"Chin J Public Health"},{"key":"R18-20260811","first-page":"589","article-title":"Study on the effect of inactivated vaccine for hemorrhagic fever type I with renal syndrome in Hunan Province on immunity (infection) enhancement and immune strategy.","volume":"015","author":"Qingzhong","year":"1999","journal-title":"Chin J Public Health"},{"key":"R19-20260811","first-page":"574","article-title":"A randomized controlled field trial of type I inactivated vaccine against hemorrhagic fever with renal syndrome in Jiande county.","volume":"15","author":"Yuhua","year":"1999","journal-title":"Chin J Public Health"},{"key":"R20-20260811","first-page":"869","article-title":"Analysis of epidemiological characteristics of hemorrhagic fever with renal syndrome in Lianyungang city.","volume":"30","author":"Jianhua","year":"2003","journal-title":"Mod Preventive Med"},{"key":"R21-20260811","first-page":"268","article-title":"Study on the immune effect and immunization strategy of kidney cell inactivated vaccine in hamsters with hemorrhagic fever with renal syndrome in Shandong Province.","volume":"7","author":"Zunbao","year":"1996","journal-title":"Chin J Vec Biol Contr"},{"key":"R22-20260811","first-page":"21","article-title":"A study on evaluation of immune effectiveness and preventive strategies of vaccines against HFRS.","volume":"7","author":"Kejian","year":"1996","journal-title":"Chin J Vec Biol Contr"},{"key":"R23-20260811","first-page":"600","article-title":"Evaluation on the efficacy of type II inactivated vaccine against HFRS prepared from tissure of hamster kidney and observation of on the spot experiment.","volume":"15","author":"Hong","year":"1999","journal-title":"Chin J Public Health"},{"key":"R24-20260811","first-page":"571","article-title":"Observation on the safety and efficacy of inactivated vaccine (type II) against HFRS.","volume":"15","author":"Meijiao","year":"1999","journal-title":"Chin J Public Health"},{"key":"R25-20260811","first-page":"12","article-title":"Observation of the effect of bivalent inactivated vaccine for hemorrhagic fever with renal syndrome 9 years after immunization.","volume":"20","author":"Xiaoping","year":"2008","journal-title":"J Prev Med"},{"key":"R26-20260811","first-page":"585","article-title":"Study on immune effects of inactivated Mongolian gerbil kidney and hamster kidney culture vaccine against HFRS cooperative group on HFRS vaccine subiect in Liaoning Province.","volume":"15","author":"Tieqiang","year":"1999","journal-title":"Chin J Public Health"},{"key":"R27-20260811","first-page":"30","article-title":"The immune effect of inactivated vaccine (type II) against HFRS and its protection to the infection of type I virus.","volume":"26","author":"Jing","year":"1998","journal-title":"Prog Microbiol Immunol"},{"key":"R28-20260811","first-page":"908","article-title":"Study on comprehensive monitoring of mouse and effect of hemorrhagic fever with renal syndrome vaccine in high prevalence areas of natural focus infectious disease of Zhejiang province in 1994--2010.","volume":"46","author":"Zhenyu","year":"2012","journal-title":"Chin J Prev Med"},{"key":"R29-20260811","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/infdis\/jiy037","article-title":"Protective effectiveness of inactivated hantavirus vaccine against hemorrhagic fever with renal syndrome.","volume":"217","author":"Jung","year":"2018","journal-title":"J Infect Dis"},{"key":"R30-20260811","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.3201\/eid1012.040684","article-title":"Protective effectiveness of hantavirus vaccine.","volume":"10","author":"Park","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"R31-20260811","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/vbz.2024.0032","article-title":"Spread of Puumala hantavirus to new areas in a large croatian outbreak of hemorrhagic fever with renal syndrome, 2021.","volume":"24","author":"Tomljenovic","year":"2024","journal-title":"Vector Borne Zoonotic Dis"},{"key":"R32-20260811","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/21645515.2016.1253645","article-title":"The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China.","volume":"13","author":"Li","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"R33-20260811","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.vaccine.2013.11.024","article-title":"The impact of the vaccination program for hemorrhagic fever with renal syndrome in Hu County, China.","volume":"32","author":"Xiao","year":"2014","journal-title":"Vaccine"},{"key":"R34-20260811","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12879-019-3794-9","article-title":"Epidemiologic study on changes in occurrence of hemorrhagic fever with renal syndrome in Republic of Korea for 17 years according to age group: 2001-2017.","volume":"19","author":"Park","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R35-20260811","first-page":"309","article-title":"Long term epidemiological effects of vaccination on hemorrhagical fever with renal syndrome (HFRS) in Shaanxi provincial HFRS epidemic areas.","volume":"33","author":"Jingjun","year":"2012","journal-title":"Chin J Epidemiol"},{"key":"R36-20260811","first-page":"3","article-title":"Study on the middle-term epidemiological efficacy of vaccines against HFRS.","volume":"17","author":"Zhenyu","year":"2001","journal-title":"Chin J Zoonoses"},{"key":"R37-20260811","first-page":"245","article-title":"Application of flow microbeads assay in detection of specific antibodies and cytokines in serum from patients with hemorrhagic fever with renal syndrome.","volume":"25","author":"Zhang","year":"2009","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"R38-20260811","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3390\/v14050901","article-title":"Neutralizing antibody titers in hospitalized patients with acute puumala orthohantavirus infection do not associate with disease severity.","volume":"14","author":"Iheozor-Ejiofor","year":"2022","journal-title":"Viruses"},{"key":"R39-20260811","first-page":"256","article-title":"Investigation of immunogenicity of purified bivalent hemorrhagic fever with renal syndrome vaccine (Veto cell) in children and the elderly.","volume":"31","author":"Min-Tian","year":"2008","journal-title":"Int J Biol"}],"updated-by":[{"DOI":"10.1097\/md.0000000000050151","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000}}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:00:23Z","timestamp":1786435223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":39,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042463","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]}}}